Financial statements Apteka 21
Balance sheet data of APTEKA 21
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 3 467 080,73 | 3 375 459,75 | 3 530 856,95 | 3 300 021,98 | 3 120 939,52 | 2 840 757,99 |
| A. Fixed assets | 81 268,60 | 71 127,54 | 72 156,25 | 64 333,22 | 65 565,43 | 64 629,37 |
| B. Current assets | 3 385 812,13 | 3 304 332,21 | 3 458 700,70 | 3 235 688,76 | 3 055 374,09 | 2 776 128,62 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 3 467 080,73 | 3 375 459,75 | 3 530 856,95 | 3 300 021,98 | 3 120 939,52 | 2 840 757,99 |
| A. Equity | 2 656 645,80 | 2 411 893,66 | 2 245 922,39 | 2 064 700,03 | 1 958 899,61 | 1 652 395,44 |
| B. Liabilities and provisions for liabilities | 810 434,93 | 963 566,09 | 1 284 934,56 | 1 235 321,95 | 1 162 039,91 | 1 188 362,55 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 778 149,05 | 903 094,13 | 1 242 265,75 | 1 207 350,25 | 1 104 923,16 | 1 116 955,89 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.